Oncology Center of Excellence (OCE) Drug Labelling Initiative

Inactive
Notice ID:FDA-RFP-1227793

Amendment 1 to FDA solicitation number: FDA-RFP-1227793 The purpose of this Amendment 1 to FDA-RFP-1227793 is to provide responses to vendor questions received before the questions submission deadline...

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   SUPPORT- PROFESSIONAL: PROGRAM MANAGEMENT/SUPPORT
LOCATION:

Links ()

Attachments ()


Data sourced from SAM.gov. View Official Posting »